schliessen

Filtern

 

Bibliotheken

Re: SUCCINCT: An Open-Label, Single-Arm, Non-Randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-Line Treatment for Patients with Advanced Urothelial Carcinoma

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2015.09.005 Byline: Sam S. Chang

Journal Title: The Journal of urology December 2015, Vol.194(6), pp.1583-4
Main Author: Chang, Sam S
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1527-3792 ; PMID: 26582660 Version:1 ; DOI: 10.1016/j.juro.2015.09.005
Link: http://pubmed.gov/26582660
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: medline26582660
title: Re: SUCCINCT: An Open-Label, Single-Arm, Non-Randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-Line Treatment for Patients with Advanced Urothelial Carcinoma
format: Article
creator:
  • Chang, Sam S
subjects:
  • Antineoplastic Combined Chemotherapy Protocols -- Toxicity
  • Bone Marrow Diseases -- Chemically Induced
  • Cisplatin -- Therapeutic Use
  • Deoxycytidine -- Analogs & Derivatives
  • Indoles -- Toxicity
  • Pyrroles -- Toxicity
  • Urologic Neoplasms -- Drug Therapy
ispartof: The Journal of urology, December 2015, Vol.194(6), pp.1583-4
description: To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2015.09.005 Byline: Sam S. Chang
language: eng
source:
identifier: E-ISSN: 1527-3792 ; PMID: 26582660 Version:1 ; DOI: 10.1016/j.juro.2015.09.005
fulltext: fulltext
issn:
  • 15273792
  • 1527-3792
url: Link


@attributes
ID1061155356
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid26582660
sourceidmedline
recordidTN_medline26582660
sourceformatXML
sourcesystemPC
pqid1735333326
galeid437421864
display
typearticle
titleRe: SUCCINCT: An Open-Label, Single-Arm, Non-Randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-Line Treatment for Patients with Advanced Urothelial Carcinoma
creatorChang, Sam S
ispartofThe Journal of urology, December 2015, Vol.194(6), pp.1583-4
identifier
subjectAntineoplastic Combined Chemotherapy Protocols -- Toxicity ; Bone Marrow Diseases -- Chemically Induced ; Cisplatin -- Therapeutic Use ; Deoxycytidine -- Analogs & Derivatives ; Indoles -- Toxicity ; Pyrroles -- Toxicity ; Urologic Neoplasms -- Drug Therapy
languageeng
source
descriptionTo link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2015.09.005 Byline: Sam S. Chang
version5
lds50peer_reviewed
links
openurl$$Topenurl_article
backlink$$Uhttp://pubmed.gov/26582660$$EView_this_record_in_MEDLINE/PubMed
openurlfulltext$$Topenurlfull_article
addlink$$Uhttp://exlibris-pub.s3.amazonaws.com/aboutMedline.html$$EView_the_MEDLINE/PubMed_Copyright_Statement
search
creatorcontribChang, Sam S
titleRe: SUCCINCT: An Open-Label, Single-Arm, Non-Randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-Line Treatment for Patients with Advanced Urothelial Carcinoma
subject
0Antineoplastic Combined Chemotherapy Protocols -- Toxicity
1Bone Marrow Diseases -- Chemically Induced
2Cisplatin -- Therapeutic Use
3Deoxycytidine -- Analogs & Derivatives
4Indoles -- Toxicity
5Pyrroles -- Toxicity
6Urologic Neoplasms -- Drug Therapy
general
026582660
1English
2MEDLINE/PubMed (U.S. National Library of Medicine)
310.1016/j.juro.2015.09.005
4MEDLINE/PubMed (NLM)
sourceidmedline
recordidmedline26582660
issn
015273792
11527-3792
rsrctypearticle
creationdate2015
addtitleThe Journal of urology
searchscope
0medline
1nlm_medline
2MEDLINE
scope
0medline
1nlm_medline
2MEDLINE
lsr41201512
citationpf 1583 vol 194 issue 6
startdate20151201
enddate20151231
lsr30VSR-Enriched:[description, galeid, pqid]
sort
titleRe: SUCCINCT: An Open-Label, Single-Arm, Non-Randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-Line Treatment for Patients with Advanced Urothelial Carcinoma
authorChang, Sam S
creationdate20151200
lso0120151200
facets
frbrgroupid8594049020493019954
frbrtype5
newrecords20190701
languageeng
creationdate2015
topic
0Antineoplastic Combined Chemotherapy Protocols–Toxicity
1Bone Marrow Diseases–Chemically Induced
2Cisplatin–Therapeutic Use
3Deoxycytidine–Analogs & Derivatives
4Indoles–Toxicity
5Pyrroles–Toxicity
6Urologic Neoplasms–Drug Therapy
collectionMEDLINE/PubMed (NLM)
prefilterarticles
rsrctypearticles
creatorcontribChang, Sam S
jtitleJournal Of Urology
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulastChang
aufirstSam S
auChang, Sam S
atitleRe: SUCCINCT: An Open-Label, Single-Arm, Non-Randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-Line Treatment for Patients with Advanced Urothelial Carcinoma
jtitleThe Journal of urology
risdate201512
volume194
issue6
spage1583
pages1583-4
issn0022-5347
eissn1527-3792
formatjournal
genrearticle
ristypeJOUR
doi10.1016/j.juro.2015.09.005
pmid26582660
date2015-12